Amman: Jordan Food and Drug Administration (JFDA) underlined the importance of administering intravenous iron infusions under medical supervision to ensure "correct" dosage and prevent potential health complications, primarily allergic reactions that may require emergency procedures due to the rare but serious risk to life. In a statement issued Sunday, the JFDA detailed that allergic reactions can surface as mild symptoms, mainly skin rash, itching, redness, a feeling of warmth or tingling, slight swelling in the face or hands, shortness of breath or wheezing, while the acute symptoms can involve anaphylactic shock, mainly severe difficulty in breathing, rapid or irregular heartbeat, and significant drops in blood pressure. The JFDA advised people, who suffered these symptoms after receiving an iron infusion, should immediately seek medical attention at the nearest hospital or emergency center. Source: Jordan News Agency
JFDA Advises Medical Supervision for Iron infusions to Avoid Health Risks
Recent Posts
UAE and Andhra Pradesh Discuss Economic Partnership at CII Summit
November 13, 2026
Euro Area Records £10.3 Billion Trade Deficit in September 2026
November 13, 2026
COP31 Unveils New Initiative for AI-Driven Climate Information Integrity
November 13, 2026
Gold Prices Rebound from Yearly Low with Modest Gains
November 13, 2026
UAE Announces Official Holidays for Private Sector on 55th Eid Al Etihad
November 13, 2026